Table 2.
Metabolite peaka | Ontology level (OL) | Metabolite | VIP | p-valueb | Fold differencec |
---|---|---|---|---|---|
0.63_148.0602m/z | OL_1 | 3-Methylaspartate | 2.6 | 1.30E−09 | − 2.5 |
OL_1 | Glutamic acid | 2.6 | 1.30E−09 | − 2.5 | |
OL_1 | N-Acetylserine | 2.6 | 1.30E−09 | − 2.5 | |
OL_2a | N-Methyl-d-aspartic acid | 2.6 | 1.30E−09 | − 2.5 | |
OL_2a | O-Acetylserine | 2.6 | 1.30E−09 | − 2.5 | |
12.14_330.2553n | OL_2b | Docosapentaenoic acid | 2.4 | 2.55E−07 | − 6.1 |
13.06_373.2733m/z | OL_1 | α-Muricholic acid | 2.4 | 2.61E−07 | − 2.6 |
OL_1 | β-Muricholic acid | 2.4 | 2.61E−07 | − 2.6 | |
OL_2b | γ-Muricholic acid | 2.4 | 2.61E−07 | − 2.6 | |
OL_2b | 7-Ketochenodeoxycholate | 2.4 | 2.61E−07 | − 2.6 | |
OL_2b | Allocholic acid | 2.4 | 2.61E−07 | − 2.6 | |
OL_2b | Cholic acid | 2.4 | 2.61E−07 | − 2.6 | |
OL_2b | Ursocholic acid | 2.4 | 2.61E−07 | − 2.6 | |
1.01_129.0787n | OL_1 | Pipecolic acid | 2.2 | 2.14E−04 | 1.8 |
16.63_437.3015m/z | OL_2a | Diosgenin | 2.1 | 2.09E−05 | 1.9 |
0.68_309.1050n | OL_2b | N-Acetylneuraminic acid | 2.1 | 2.41E−06 | − 2.0 |
17.26_568.4279n | OL_2a | Lutein | 2.0 | 1.41E−05 | 2.9 |
11.74_430.2950m/z | OL_2b | Glycylcholic acid | 2.0 | 2.35E−05 | − 3.2 |
0.74_308.0903m/z | OL_1 | Reduced glutathione | 1.9 | 3.66E−05 | 2.3 |
13.46_243.2100m/z | OL_2b | γ-Linolenic acid | 1.9 | 5.88E−05 | 5.9 |
11.22_347.2213m/z | OL_1 | Cortexolone | 1.9 | 4.56E−05 | − 1.9 |
OL_1 | Corticosterone | 1.9 | 4.56E−05 | − 1.9 | |
9.98_288.1587m/z | OL_2b | Dihydromorphine | 1.8 | 1.63E−04 | − 4.1 |
4.31_134.0599m/z | OL_2a | Acetaminophen | 1.7 | 1.70E−02 | − 1.9 |
16.16_432.3234n | OL_2b | 1,24,25-Trihydroxyvitamin D3 | 1.7 | 2.58E−03 | − 1.8 |
4.70_144.0806m/z | OL_1 | Tryptamine | 1.7 | 7.73E−04 | 2.0 |
OL_2b | 3-(2-Hydroxyethyl)indole | 1.7 | 7.73E−04 | 2.0 | |
15.68_430.3081n | OL_2b | 7α-hydroxy-3-oxo-4-cholestenoic acid | 1.7 | 8.45E−04 | 6.7 |
5.31_228.0625m/z | OL_2b | Indolelactic acid | 1.6 | 1.78E−03 | − 2.7 |
OL_2b | trans-Cinnamoylglycine | 1.6 | 1.78E−03 | − 2.7 | |
10.85_180.1015m/z | OL_2a | Propham | 1.6 | 1.15E−03 | − 4.4 |
OL_2b | Salsolinol | 1.6 | 1.15E−03 | − 4.4 | |
0.58_188.1520n | OL_1 | N,N,N-Trimethyllysine | 1.6 | 2.57E−04 | − 1.9 |
OL_2b | Propamocarb free base | 1.6 | 2.57E−04 | − 1.9 | |
1.48_190.0704m/z | OL_1 | N-Acetylglutamate | 1.6 | 5.15E−03 | − 1.8 |
OL_2a | 3-Dehydroshikimic acid | 1.6 | 5.15E−03 | − 1.8 | |
4.83_268.1511m/z | OL_1 | 2-Methylbutyroylcarnitine | 1.6 | 1.01E−02 | − 1.8 |
OL_1 | Isovaleryl-l-carnitine | 1.6 | 1.01E−02 | − 1.8 | |
OL_1 | Valeryl-l-carnitine | 1.6 | 1.01E−02 | − 1.8 | |
7.79_206.0809m/z | OL_1 | trans-Cinnamoylglycine | 1.5 | 9.80E−04 | 2.5 |
OL_2a | Dioxacarb | 1.5 | 9.80E−04 | 2.5 | |
16.78_328.2392n | OL_2b | Docosahexaenoic acid | 1.5 | 2.52E−03 | 2.1 |
7.79_148.0523n | OL_2b | trans-Cinnamic acid | 1.5 | 1.93E−03 | 2.6 |
14.13_392.2921n | OL_2b | Sodium deoxycholate | 1.5 | 1.20E−03 | − 1.8 |
OL_2b | Chenodeoxycholic acid | 1.5 | 1.20E−03 | − 1.8 | |
OL_2b | Murideoxycholic acid | 1.5 | 1.20E−03 | − 1.8 | |
0.96_117.0428n | OL_1 | N-Acetylglycine | 1.5 | 5.17E−04 | 1.8 |
0.83_277.1025m/z | OL_2a | Pseudouridine | 1.5 | 8.86E−04 | − 1.8 |
1.01_82.0651m/z | OL_2a | 5-Aminopentanoate | 1.4 | 8.73E−03 | 2.0 |
OL_2a | Betaine | 1.4 | 8.73E−03 | 2.0 | |
OL_2a | Nicotine | 1.4 | 8.73E−03 | 2.0 | |
9.25_150.0677n | OL_1 | Hydrocinnamic acid | 1.4 | 7.82E−03 | 1.9 |
1.01_160.0602m/z | OL_2a | Glucosaminate | 1.4 | 4.96E−03 | 2.6 |
OL_2a | 1-Methylnicotinamide | 1.4 | 4.96E−03 | 2.6 | |
11.48_266.1382m/z | OL_2a | Monocyclohexyl phthalate | 1.4 | 1.54E−03 | − 2.5 |
5.82_170.0210m/z | OL_2a | trans-4-Hydroxy-l-proline | 1.6 | 1.71E−03 | − 1.8 |
1.53_248.1484m/z | OL_1 | Hydroxybutyrylcarnitine | 1.4 | 6.57E−03 | − 2.4 |
OL_2b | Prometon | 1.4 | 6.57E−03 | − 2.4 | |
11.37_334.2139n | OL_2b | Prostaglandin B2 | 1.4 | 5.06E−03 | 4.1 |
13.46_392.2921n | OL_1 | Ursodeoxycholate | 1.4 | 2.74E−03 | − 2.3 |
OL_1 | Murideoxycholic acid | 1.4 | 2.74E−03 | − 2.3 | |
OL_2b | Deoxycholic acid | 1.4 | 2.74E−03 | − 2.3 | |
OL_2b | Chenodeoxycholic acid | 1.4 | 2.74E−03 | − 2.3 | |
13.46_339.2677m/z | OL_2b | Dehydrolithocholic acid | 1.4 | 2.92E−03 | − 2.8 |
8.72_416.3156m/z | OL_2b | Glycolithocholic acid | 1.4 | 3.62E−03 | − 2.0 |
5.31_179.0581n | OL_1 | Hippuric acid | 1.4 | 5.55E−03 | 1.8 |
14.16_401.2658m/z | OL_1 | Nordeoxycholic acid | 1.3 | 6.63E−03 | − 1.8 |
7.86_260.0887m/z | OL_2a | 3-Hydroxycarbofuran | 1.3 | 4.78E−03 | − 2.1 |
0.74_365.1050m/z | OL_1 | Lactose | 1.3 | 6.49E−03 | − 1.9 |
OL_1 | Sucrose | 1.3 | 6.49E−03 | − 1.9 | |
OL_1 | Trehalose dihydrate | 1.3 | 6.49E−03 | − 1.9 | |
OL_2a | Palatinose | 1.3 | 6.49E−03 | − 1.9 | |
17.15_316.2514m/z | OL_2a | Adrenic acid | 1.3 | 9.31E−03 | 3.5 |
14.19_252.6229m/z | OL_2a | N-Acetyl leukotriene E4 | 1.3 | 3.34E−02 | − 2.2 |
16.85_401.3408m/z | OL_1 | 7-Ketocholesterol | 1.3 | 8.46E−03 | − 2.2 |
OL_1 | 7α-Hydroxy-4-cholesten-3-one | 1.3 | 8.46E−03 | − 2.2 | |
11.03_357.2032m/z | OL_2b | Prostaglandin B2 | 1.3 | 8.85E−03 | 2.3 |
0.74_216.1226m/z | OL_2a | Epinephrine | 1.3 | 4.23E−02 | 1.9 |
7.00_219.0624m/z | OL_2b | 3,4-Dimethoxyphenylacetic acid | 1.2 | 1.66E−02 | 3.8 |
8.55_233.0778m/z | OL_1 | 3,4-Dimethoxyphenylpropanoic acid | 1.2 | 1.85E−02 | 2.1 |
10.79_375.2138m/z | OL_2b | Prostaglandin E2 | 1.2 | 2.40E−02 | 2.1 |
2.45_160.0756m/z | OL_2b | Indoleacetaldehyde | 1.2 | 2.87E−02 | 2.1 |
OL_1 | Serotonin | 1.2 | 2.87E−02 | 2.1 | |
7.33_173.1048n | OL_1 | Hexanoyl glycine | 1.2 | 6.64E−03 | 2.8 |
OL_2b | N-Acetylleucine | 1.2 | 6.64E−03 | 2.8 | |
9.57_189.0784n | OL_2b | IndolE−3-propionic acid | 1.2 | 1.14E−02 | − 2.3 |
OL_2a | IndolE−3-methyl acetate | 1.2 | 1.14E−02 | − 2.3 | |
15.73_433.3307m/z | OL_2a | Coprocholic acid | 1.2 | 1.15E−02 | − 2.2 |
8.55_151.0749m/z | OL_2a | (3,4-Dimethoxyphenyl)methanol | 1.2 | 1.96E−02 | 2.0 |
OL_2b | 2-Phenylpropionate | 1.2 | 1.96E−02 | 2.0 | |
OL_2b | 3-Phenylpropanoic acid | 1.2 | 1.96E−02 | 2.0 | |
1.01_147.0649m/z | OL_2a | Fucose | 1.2 | 2.52E−02 | − 3.0 |
OL_2a | Galactitol | 1.2 | 2.52E−02 | − 3.0 | |
OL_2a | Sorbitol | 1.2 | 2.52E−02 | − 3.0 | |
2.45_160.0756m/z | OL_2a | Cotinine | 1.2 | 2.87E−02 | 2.1 |
1.01_199.0211m/z | OL_1 | Glucuronic acid-lactone | 1.2 | 8.76E−03 | − 3.1 |
OL_1 | Ascorbic acid | 1.2 | 8.76E−03 | − 3.1 | |
4.74_134.0598m/z | OL_2b | Norepinephrine | 1.1 | 2.38E−02 | − 2.3 |
12.17_331.1146m/z | OL_2b | Mono (5-carboxy-2-ethylpentyl) phthalate | 1.1 | 1.58E−02 | − 4.4 |
7.55_183.0647m/z | OL_2a | 3,4-Dimethoxybenzoic acid | 1.2 | 6.37E−02 | 1.9 |
OL_2a | 2,4-Dimethoxybenzoic acid | 1.2 | 6.37E−02 | 1.9 | |
OL_2b | 1,3-Dimethyluric acid | 1.2 | 7.63E−02 | − 1.8 | |
5.56_146.0689n | OL_2b | Glutamine | 1.1 | 1.12E−02 | − 1.8 |
10.46_301.1314n | OL_2b | 10-Hydroxymorphine | 1.1 | 3.09E−02 | − 2.0 |
OL_2b | Fenoxycarb | 1.1 | 3.09E−02 | − 2.0 | |
OL_2b | Furalaxyl | 1.1 | 3.09E−02 | − 2.0 | |
OL_2b | Oxymorphone | 1.1 | 3.09E−02 | − 2.0 | |
OL_2b | MorphinE-N-oxide | 1.1 | 3.09E−02 | − 2.0 | |
16.56_285.2204m/z | OL_1 | 13-cis-retinal | 1.1 | 2.33E−02 | 2.7 |
OL_2b | Eicosapentaenoic acid | 1.1 | 2.33E−02 | 2.7 | |
0.74_189.1229m/z | OL_1 | N-α-Acetyllysine | 1.1 | 3.84E−02 | − 1.9 |
13.72_495.3445m/z | OL_2a | 2,6-di-tert-butyl-4-hydroxy-4-methylcyclohexa-2,5-dien-1-one | 1.1 | 7.11E−02 | 4.4 |
9.79_183.0800m/z | OL_2b | 9-Hydroxyfluorene | 1.0 | 3.47E−02 | − 2.2 |
5.31_175.0363m/z | OL_2a | 4-hydroxyphenylacetic acid | 1.0 | 3.44E−02 | − 4.2 |
1.07_138.0524m/z | OL_2a | Proline | 1.0 | 3.51E−02 | − 3.7 |
5.56_491.1998m/z | OL_2a | Folinic acid | 1.0 | 3.08E−02 | − 2.0 |
The table is sorted by Variable Influence on Projection (VIP). See Supplementary Table S4 for additional important metabolite peaks with statistics.
aMass spectrometry metabolomics platforms cannot always distinguish between isomers, and multiple peaks may match the same compound. Additionally, one peak may match multiple metabolites due to adduct formation or isobaric compounds. For the complete list of metabolites annotations or identifications of metabolite peaks see Supplementary Tables S1 and S2.
bt-test with Satterthwaite correction for unequal variances.
cPositive fold difference indicates that the mean value for the LIFE group was greater than for the CON group.